메뉴 건너뛰기




Volumn 135, Issue 1, 2012, Pages 29-37

Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma

Author keywords

Estrogen receptor; Her 2 neu receptor; Local recurrence; Lymph node; Metastasis; Neoadjuvant chemotherapy; Progesterone receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GROWTH HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

EID: 84865133552     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2047-z     Document Type: Review
Times cited : (45)

References (59)
  • 1
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative G.
    • Early Breast Cancer Trialists' Collaborative G (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687-1717. doi: 10.1016/S0140-6736(05)66544-0
    • (2005) Lancet , vol.365 , Issue.9472 , pp. 1687-1717
  • 4
    • 77951952801 scopus 로고    scopus 로고
    • Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
    • 10.1093/annonc/mdp427
    • Aitken SJ, Thomas JS, Langdon SP, Harrison DJ, Faratian D (2010) Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol 21(6):1254-1261. doi: 10.1093/annonc/mdp427
    • (2010) Ann Oncol , vol.21 , Issue.6 , pp. 1254-1261
    • Aitken, S.J.1    Thomas, J.S.2    Langdon, S.P.3    Harrison, D.J.4    Faratian, D.5
  • 5
    • 0025952428 scopus 로고
    • Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer
    • 2065272 10.1002/1097-0142(19910801)68:3<532::AID-CNCR2820680314>3. 0.CO;2-G 1:STN:280:DyaK3M3pt1Cjsw%3D%3D
    • Mori T, Morimoto T, Komaki K, Monden Y (1991) Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer. Cancer 68(3):532-537
    • (1991) Cancer , vol.68 , Issue.3 , pp. 532-537
    • Mori, T.1    Morimoto, T.2    Komaki, K.3    Monden, Y.4
  • 7
    • 77955472477 scopus 로고    scopus 로고
    • Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
    • 10.1007/s00268-010-0499-z
    • Falck AK, Ferno M, Bendahl PO, Ryden L (2010) Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer? World J Surg 34(7):1434-1441. doi: 10.1007/s00268-010-0499-z
    • (2010) World J Surg , vol.34 , Issue.7 , pp. 1434-1441
    • Falck, A.K.1    Ferno, M.2    Bendahl, P.O.3    Ryden, L.4
  • 8
    • 79959936894 scopus 로고    scopus 로고
    • Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: Clinical implications of progesterone receptor loss
    • 10.1007/s00428-011-1097-7
    • Bogina G, Bortesi L, Marconi M, Venturini M, Lunardi G, Coati F, Massocco A, Manfrin E, Pegoraro C, Zamboni G (2011) Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss. Virchows Arch 459(1):1-10. doi: 10.1007/s00428-011-1097-7
    • (2011) Virchows Arch , vol.459 , Issue.1 , pp. 1-10
    • Bogina, G.1    Bortesi, L.2    Marconi, M.3    Venturini, M.4    Lunardi, G.5    Coati, F.6    Massocco, A.7    Manfrin, E.8    Pegoraro, C.9    Zamboni, G.10
  • 9
    • 58049217550 scopus 로고    scopus 로고
    • Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer
    • 10.1309/AJCPD1AO3YSYQYNW
    • Gomez-Fernandez C, Daneshbod Y, Nassiri M, Milikowski C, Alvarez C, Nadji M (2008) Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer. Am J Clin Pathol 130(6):879-882. doi: 10.1309/AJCPD1AO3YSYQYNW
    • (2008) Am J Clin Pathol , vol.130 , Issue.6 , pp. 879-882
    • Gomez-Fernandez, C.1    Daneshbod, Y.2    Nassiri, M.3    Milikowski, C.4    Alvarez, C.5    Nadji, M.6
  • 11
    • 0021954433 scopus 로고
    • The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas
    • DOI 10.1007/BF01805989
    • Hahnel R, Twaddle E (1985) The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas. Breast Cancer Res Treat 5(2):155-163 (Pubitemid 15124774)
    • (1985) Breast Cancer Research and Treatment , vol.5 , Issue.2 , pp. 155-163
    • Hahnel, R.1    Twaddle, E.2
  • 12
    • 77949391758 scopus 로고    scopus 로고
    • Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance
    • 10.1309/AJCPJ57FLLJRXKPV
    • Idirisinghe PK, Thike AA, Cheok PY, Tse GM, Lui PC, Fook-Chong S, Wong NS, Tan PH (2010) Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance. Am J Clin Pathol 133(3):416-429. doi: 10.1309/AJCPJ57FLLJRXKPV
    • (2010) Am J Clin Pathol , vol.133 , Issue.3 , pp. 416-429
    • Idirisinghe, P.K.1    Thike, A.A.2    Cheok, P.Y.3    Tse, G.M.4    Lui, P.C.5    Fook-Chong, S.6    Wong, N.S.7    Tan, P.H.8
  • 13
    • 16844383643 scopus 로고    scopus 로고
    • Impact of metastatic estrogen receptor and progesterone receptor status on survival
    • DOI 10.1007/s10549-004-2756-z
    • Lower EE, Glass EL, Bradley DA, Blau R, Heffelfinger S (2005) Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast Cancer Res Treat 90(1):65-70. doi: 10.1007/s10549-004-2756-z (Pubitemid 40487003)
    • (2005) Breast Cancer Research and Treatment , vol.90 , Issue.1 , pp. 65-70
    • Lower, E.E.1    Glass, E.L.2    Bradley, D.A.3    Blau, R.4    Heffelfinger, S.5
  • 14
    • 0017756237 scopus 로고
    • Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer
    • Rosen PP, Menendez-Botet CJ, Urban JA, Fracchia A, Schwartz MK (1977) Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer. Cancer 39(5):2194-2200 (Pubitemid 8129057)
    • (1977) Cancer , vol.39 , Issue.5 , pp. 2194-2200
    • Rosen, P.P.1    Menendez Botet, C.J.2    Urban, J.A.3
  • 15
    • 0033979132 scopus 로고    scopus 로고
    • C-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues
    • DOI 10.1002/(SICI)1096-9098(200001)73:1<17::AID-JSO5>3.0.CO;2-2
    • Shimizu C, Fukutomi T, Tsuda H, Akashi-Tanaka S, Watanabe T, Nanasawa T, Sugihara K (2000) c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues. J Surg Oncol 73(1):17-20. doi: 10.1002/(SICI)1096-9098(200001)73:1<17:AID-JSO5>3.0.CO;2-2 (Pubitemid 30067528)
    • (2000) Journal of Surgical Oncology , vol.73 , Issue.1 , pp. 17-20
    • Shimizu, C.1    Fukutomi, T.2    Tsuda, H.3    Akashi-Tanaka, S.4    Watanabe, T.5    Nanasawa, T.6    Sugihara, K.7
  • 16
    • 0032423729 scopus 로고    scopus 로고
    • Steroid hormone receptors in breast cancer management
    • DOI 10.1023/A:1006132427948
    • Osborne CK (1998) Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51(3):227-238 (Pubitemid 29054556)
    • (1998) Breast Cancer Research and Treatment , vol.51 , Issue.3 , pp. 227-238
    • Osborne, C.K.1
  • 17
    • 0025789867 scopus 로고
    • Estrogen receptor variants in clinical breast cancer
    • 1779964 10.1210/mend-5-11-1571 1:CAS:528:DyaK38XhvFSmug%3D%3D
    • McGuire WL, Chamness GC, Fuqua SA (1991) Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5(11):1571-1577
    • (1991) Mol Endocrinol , vol.5 , Issue.11 , pp. 1571-1577
    • McGuire, W.L.1    Chamness, G.C.2    Fuqua, S.A.3
  • 18
    • 0021924507 scopus 로고
    • Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer
    • DOI 10.1002/1097-0142(19850201)55:3<546::AID-CNCR2820550313>3.0. CO;2-V
    • Nomura Y, Tashiro H, Shinozuka K (1985) Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer. Cancer 55(3):546-551 (Pubitemid 15156022)
    • (1985) Cancer , vol.55 , Issue.3 , pp. 546-551
    • Nomura, Y.1    Tashiro, H.2    Shinozuka, K.3
  • 19
    • 0021773409 scopus 로고
    • Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer
    • 6730015 1:STN:280:DyaL2c3isFamtg%3D%3D
    • Coradini D, Cappelletti V, Miodini P, Ronchi E, Scavone G, Di Fronzo G (1984) Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer. Tumori 70(2):165-168
    • (1984) Tumori , vol.70 , Issue.2 , pp. 165-168
    • Coradini, D.1    Cappelletti, V.2    Miodini, P.3    Ronchi, E.4    Scavone, G.5    Di Fronzo, G.6
  • 20
    • 0020596899 scopus 로고
    • Variation in receptor status between primary and metastatic breast cancer
    • Holdaway IM, Bowditch JV (1983) Variation in receptor status between primary and metastatic breast cancer. Cancer 52(3):479-485 (Pubitemid 13073476)
    • (1983) Cancer , vol.52 , Issue.3 , pp. 479-485
    • Holdaway, I.M.1    Bowditch, J.V.2
  • 21
    • 0019131748 scopus 로고
    • Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer
    • Paridaens R, Sylvester RJ, Ferrazzi E, Legros N, Leclercq G, Heuson JC (1980) Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 46(12 Suppl):2889-2895 (Pubitemid 11205653)
    • (1980) Cancer , vol.46 , Issue.12 SUPPL. , pp. 2889-2895
    • Paridaens, R.1    Sylvester, R.J.2    Ferrazzi, E.3
  • 22
    • 0029113686 scopus 로고
    • Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer
    • 7614468 1:CAS:528:DyaK2MXnt1ansb4%3D
    • Johnston SR, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR, Dowsett M (1995) Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55(15):3331-3338
    • (1995) Cancer Res , vol.55 , Issue.15 , pp. 3331-3338
    • Johnston, S.R.1    Saccani-Jotti, G.2    Smith, I.E.3    Salter, J.4    Newby, J.5    Coppen, M.6    Ebbs, S.R.7    Dowsett, M.8
  • 23
    • 77955900486 scopus 로고    scopus 로고
    • Discordance in hormone receptor status in breast cancer during tumor progression
    • (abstr 1009)
    • Karlsson E, Lindström LS, Wilking U, Skoog L, Johansson U, Bergh J (2010) Discordance in hormone receptor status in breast cancer during tumor progression. J Clin Oncol 28(suppl 15):116s (abstr 1009)
    • (2010) J Clin Oncol , vol.28 , Issue.SUPPL 15
    • Karlsson, E.1    Lindström, L.S.2    Wilking, U.3    Skoog, L.4    Johansson, U.5    Bergh, J.6
  • 29
    • 58149237085 scopus 로고    scopus 로고
    • HER-2/neu expression in primary and metastatic breast cancer
    • 10.1007/s10549-008-9931-6
    • Lower EE, Glass E, Blau R, Harman S (2009) HER-2/neu expression in primary and metastatic breast cancer. Breast Cancer Res Treat 113(2):301-306. doi: 10.1007/s10549-008-9931-6
    • (2009) Breast Cancer Res Treat , vol.113 , Issue.2 , pp. 301-306
    • Lower, E.E.1    Glass, E.2    Blau, R.3    Harman, S.4
  • 31
    • 0037534031 scopus 로고    scopus 로고
    • Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome
    • DOI 10.1002/jso.10243
    • Iguchi C, Nio Y, Itakura M (2003) Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome. J Surg Oncol 83(2):85-93. doi: 10.1002/jso.10243 (Pubitemid 36667416)
    • (2003) Journal of Surgical Oncology , vol.83 , Issue.2 , pp. 85-93
    • Iguchi, C.1    Nio, Y.2    Itakura, M.3
  • 32
    • 0024348260 scopus 로고
    • Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence
    • Kamby C, Rasmussen BB, Kristensen B (1989) Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence. Br J Cancer 60(2):252-257 (Pubitemid 19207850)
    • (1989) British Journal of Cancer , vol.60 , Issue.2 , pp. 252-257
    • Kamby, C.1    Rasmussen, B.B.2    Kristensen, B.3
  • 33
    • 38149032775 scopus 로고    scopus 로고
    • Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers
    • 10.1016/j.humpath.2007.06.012
    • Liu H, Fan Q, Zhang Z, Li X, Yu H, Meng F (2008) Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers. Hum Pathol 39(2):167-174. doi: 10.1016/j.humpath.2007. 06.012
    • (2008) Hum Pathol , vol.39 , Issue.2 , pp. 167-174
    • Liu, H.1    Fan, Q.2    Zhang, Z.3    Li, X.4    Yu, H.5    Meng, F.6
  • 34
    • 69549138175 scopus 로고    scopus 로고
    • Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas
    • 10.1111/j.1365-2559.2009.03380.x
    • Fernandes RC, Bevilacqua JL, Soares IC, Siqueira SA, Pires L, Hegg R, Carvalho FM (2009) Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas. Histopathology 55(3):346-352. doi: 10.1111/j.1365-2559.2009.03380.x
    • (2009) Histopathology , vol.55 , Issue.3 , pp. 346-352
    • Fernandes, R.C.1    Bevilacqua, J.L.2    Soares, I.C.3    Siqueira, S.A.4    Pires, L.5    Hegg, R.6    Carvalho, F.M.7
  • 35
    • 80051518360 scopus 로고    scopus 로고
    • A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis
    • 21874118 10.3747/co.v18i4.815 1:STN:280:DC%2BC3MjpsFWgtQ%3D%3D
    • Hamm C, El-Masri M, Poliquin G, Poliquin V, Mathews J, Kanjeekal S, Alam Y, Kulkarni S, Elfiki T (2011) A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis. Curr Oncol 18(4):191-196
    • (2011) Curr Oncol , vol.18 , Issue.4 , pp. 191-196
    • Hamm, C.1    El-Masri, M.2    Poliquin, G.3    Poliquin, V.4    Mathews, J.5    Kanjeekal, S.6    Alam, Y.7    Kulkarni, S.8    Elfiki, T.9
  • 36
    • 53149134670 scopus 로고    scopus 로고
    • Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy
    • 10.1016/j.breast.2008.04.002
    • Kasami M, Uematsu T, Honda M, Yabuzaki T, Sanuki J, Uchida Y, Sugimura H (2008) Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy. Breast 17(5):523-527. doi: 10.1016/j.breast.2008.04.002
    • (2008) Breast , vol.17 , Issue.5 , pp. 523-527
    • Kasami, M.1    Uematsu, T.2    Honda, M.3    Yabuzaki, T.4    Sanuki, J.5    Uchida, Y.6    Sugimura, H.7
  • 37
    • 84655170220 scopus 로고    scopus 로고
    • Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer
    • 10.1007/s12032-010-9676-z
    • Li XR, Liu M, Zhang YJ, Wang JD, Zheng YQ, Li J, Ma B, Song X (2010) Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer. Med Oncol. doi: 10.1007/s12032-010-9676-z
    • (2010) Med Oncol
    • Li, X.R.1    Liu, M.2    Zhang, Y.J.3    Wang, J.D.4    Zheng, Y.Q.5    Li, J.6    Ma, B.7    Song, X.8
  • 38
    • 40349088610 scopus 로고    scopus 로고
    • The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and Her2/neu status in breast carcinoma
    • DOI 10.1111/j.1524-4741.2007.00544.x
    • Adams AL, Eltoum I, Krontiras H, Wang W, Chhieng DC (2008) The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and HER2/neu status in breast carcinoma. Breast J 14(2):141-146. doi: 10.1111/j.1524-4741.2007.00544.x (Pubitemid 351341835)
    • (2008) Breast Journal , vol.14 , Issue.2 , pp. 141-146
    • Adams, A.L.1    Eltoum, I.2    Krontiras, H.3    Wang, W.4    Chhieng, D.C.5
  • 39
    • 77950270960 scopus 로고    scopus 로고
    • Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: Emerging questions and considerations addressed
    • 10.1097/PAS.0b013e3181d65639
    • D'Alfonso T, Liu YF, Monni S, Rosen PP, Shin SJ (2010) Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed. Am J Surg Pathol 34(4):575-581. doi: 10.1097/PAS.0b013e3181d65639
    • (2010) Am J Surg Pathol , vol.34 , Issue.4 , pp. 575-581
    • D'Alfonso, T.1    Liu, Y.F.2    Monni, S.3    Rosen, P.P.4    Shin, S.J.5
  • 41
    • 73849124317 scopus 로고    scopus 로고
    • Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells
    • 10.1158/1541-7786.MCR-09-0188
    • Bolanz KA, Kovacs GG, Landowski CP, Hediger MA (2009) Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells. Mol Cancer Res 7(12):2000-2010. doi: 10.1158/1541-7786.MCR-09-0188
    • (2009) Mol Cancer Res , vol.7 , Issue.12 , pp. 2000-2010
    • Bolanz, K.A.1    Kovacs, G.G.2    Landowski, C.P.3    Hediger, M.A.4
  • 42
    • 0024841189 scopus 로고
    • Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer
    • Brunn Rasmussen B, Kamby C (1989) Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer. Pathol Res Pract 185(6):856-859 (Pubitemid 20070797)
    • (1989) Pathology Research and Practice , vol.185 , Issue.6 , pp. 856-859
    • Rasmussen, B.B.1    Kamby, C.2
  • 46
    • 33644833525 scopus 로고    scopus 로고
    • Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes
    • 10.1111/j.1742-1241.2005.00546.x
    • Dikicioglu E, Barutca S, Meydan N, Meteoglu I (2005) Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes. Int J Clin Pract 59(9):1039-1044. doi: 10.1111/j.1742-1241.2005.00546.x
    • (2005) Int J Clin Pract , vol.59 , Issue.9 , pp. 1039-1044
    • Dikicioglu, E.1    Barutca, S.2    Meydan, N.3    Meteoglu, I.4
  • 49
    • 0033868761 scopus 로고    scopus 로고
    • Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: An immunohistochemical study
    • Masood S, Bui MM (2000) Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study. Ann Clin Lab Sci 30(3):259-265 (Pubitemid 30620800)
    • (2000) Annals of Clinical and Laboratory Science , vol.30 , Issue.3 , pp. 259-265
    • Masood, S.1    Bui, M.M.2
  • 51
    • 4143090608 scopus 로고    scopus 로고
    • Change of HER-2/neu status in a subset of distant metastases from breast carcinomas
    • DOI 10.1002/path.1592
    • Regitnig P, Schippinger W, Lindbauer M, Samonigg H, Lax SF (2004) Change of HER-2/neu status in a subset of distant metastases from breast carcinomas. J Pathol 203(4):918-926. doi: 10.1002/path.1592 (Pubitemid 39089280)
    • (2004) Journal of Pathology , vol.203 , Issue.4 , pp. 918-926
    • Regitnig, P.1    Schippinger, W.2    Lindbauer, M.3    Samonigg, H.4    Lax, S.F.5
  • 52
    • 69849090104 scopus 로고    scopus 로고
    • Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
    • 10.1093/annonc/mdp028
    • Simmons C, Miller N, Geddie W, Gianfelice D, Oldfield M, Dranitsaris G, Clemons MJ (2009) Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? Ann Oncol 20(9):1499-1504. doi: 10.1093/annonc/mdp028
    • (2009) Ann Oncol , vol.20 , Issue.9 , pp. 1499-1504
    • Simmons, C.1    Miller, N.2    Geddie, W.3    Gianfelice, D.4    Oldfield, M.5    Dranitsaris, G.6    Clemons, M.J.7
  • 53
    • 0035878845 scopus 로고    scopus 로고
    • Amplification of HER-2/neu and Topoisomerase IIα in primary and metastatic breast cancer
    • Tanner M, Jarvinen P, Isola J (2001) Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer. Cancer Res 61(14):5345-5348 (Pubitemid 32694907)
    • (2001) Cancer Research , vol.61 , Issue.14 , pp. 5345-5348
    • Tanner, M.1    Jarvinen, P.2    Isola, J.3
  • 55
    • 0036620235 scopus 로고    scopus 로고
    • EGFR, c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer
    • 12099646 10.1053/ejso.2002.1259 1:STN:280:DC%2BD38zlslShug%3D%3D
    • Tsutsui S, Ohno S, Murakami S, Kataoka A, Kinoshita J, Hachitanda Y (2002) EGFR, c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer. Eur J Surg Oncol 28(4):383-387
    • (2002) Eur J Surg Oncol , vol.28 , Issue.4 , pp. 383-387
    • Tsutsui, S.1    Ohno, S.2    Murakami, S.3    Kataoka, A.4    Kinoshita, J.5    Hachitanda, Y.6
  • 56
    • 0029642255 scopus 로고
    • Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer
    • 8847135 10.1002/ijc.2910630607
    • van Agthoven T, Timmermans M, Dorssers LC, Henzen-Logmans SC (1995) Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer. Int J Cancer 63(6):790-793
    • (1995) Int J Cancer , vol.63 , Issue.6 , pp. 790-793
    • Van Agthoven, T.1    Timmermans, M.2    Dorssers, L.C.3    Henzen-Logmans, S.C.4
  • 57
    • 0036180273 scopus 로고    scopus 로고
    • Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material
    • DOI 10.1038/modpathol.3880503
    • Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H (2002) Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Mod Pathol 15(2):116-124. doi: 10.1038/modpathol.3880503 (Pubitemid 34171321)
    • (2002) Modern Pathology , vol.15 , Issue.2 , pp. 116-124
    • Xu, R.1    Perle, M.A.2    Inghirami, G.3    Chan, W.4    Delgado, Y.5    Feiner, H.6
  • 58
    • 26944465031 scopus 로고    scopus 로고
    • Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease
    • DOI 10.1038/sj.bjc.6602738, PII 6602738
    • Zidan J, Dashkovsky I, Stayerman C, Basher W, Cozacov C, Hadary A (2005) Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease. Br J Cancer 93(5):552-556. doi: 10.1038/sj.bjc.6602738 (Pubitemid 43079998)
    • (2005) British Journal of Cancer , vol.93 , Issue.5 , pp. 552-556
    • Zidan, J.1    Dashkovsky, I.2    Stayerman, C.3    Basher, W.4    Cozacov, C.5    Hadary, A.6
  • 59
    • 33644836395 scopus 로고    scopus 로고
    • HER-2/neu expression in locally advanced breast carcinomas: Pre-and post-neoadjuvant chemotherapy
    • 16286910 10.2325/jbcs.12.294
    • Quddus RM, Sung JC, Zhang C, Pasqueriello T, Eklund M, Steinhoff MM (2005) HER-2/neu expression in locally advanced breast carcinomas: pre-and post-neoadjuvant chemotherapy. Breast Cancer 12(4):294-298
    • (2005) Breast Cancer , vol.12 , Issue.4 , pp. 294-298
    • Quddus, R.M.1    Sung, J.C.2    Zhang, C.3    Pasqueriello, T.4    Eklund, M.5    Steinhoff, M.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.